Dec 13,2022

BehaVR and OxfordVR Combine and Raise Series B to Create Largest VR Delivery Platform for Evidence-Based Digital Therapeutics

Virtual reality mental and behavioral health companies BehaVR and OxfordVR today announced their merger, supported by an initial $13 million in Series B funding led by Optum Ventures and Oxford Science Enterprises, with participation from Confluent Health, Accenture Ventures, Chrysalis Ventures and Thornton Capital.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Apr 08,2020

SilverCloud Health Announces $16M Series B Funding for Digital Mental Health Platform

SilverCloud Health, the world's leading digital mental health platform for healthcare systems and providers, health plans, and employers, today announced a $16 million Series B funding round led by MemorialCare Innovation Fund, which included LRVHealth, OSF Ventures and UnityPoint Health Ventures, elevating the company’s total funding to more than $30 million. Existing investors Act Venture Capital and B Capital Group participated in the round as well.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Jun 18,2020

Sleep, stress app maker Big Health locks in $39M Series B raise

Big Health, maker of digital health apps targeting poor sleep, worry and anxiety, has announced a $39 million Series B raise. Gilde Health and Morningside Ventures headlined the funding. Samsung NEXT also participated in the raise, as did prior backers Kaiser Permanente Ventures and Octopus Ventures. The digital behavioral health company said that the raise will support new product development, as well as growth of its distribution channels and commercialization efforts.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Jun 19,2020

Kaia Health Lands $26M to Expand AI-Driven Digital Therapeutics for MSK Conditions & COPD

Kaia Health, a digital therapeutics company focused on helping people manage chronic conditions, today announced that it closed a $26 million Series B funding round, bringing its total funds raised to date to $50 million. The round was led by Optum Ventures, Idinvest, and capital300 with participation from existing investors Balderton Capital and Heartcore Capital, as well as Symphony Ventures (an investment partnership with world #1 golfer Rory McIlroy). Kaia Health will use the proceeds to drive the growth of its core digital therapy solutions for people managing musculoskeletal (MSK) conditions, and fund expansion into new conditions such as COPD, where its digitally delivered multi-modal therapy is also clinically effective.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Sep 18,2020

Swedish digital health firm Joint Academy raises $23M in Series B round

Swedish firm Joint Academy has raised $23 million in Series B funding for its clinical evidence-based digital treatment for chronic joint pain, which connects patients with licensed physical therapists. The round was led by international investment company Kinnevik and participated in by existing investors Karl-Johan Persson (H&M chairman) and Alfvén & Didrikso. To date, the company, which was previously known as Artho Therapeutics, has raised $34.2 million. Since being founded in 2014, Joint Academy has treated 25,000 patients who suffer from chronic hip and knee pain through its app.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Mar 18,2019

Theranica Raises $35M to Bring Innovative Migraine Device to the USA aMoon leads round B of financing of the Israel-based company

Theranica, a bio-medical technology company developing advanced electroceuticals for migraine and other prevalent diseases, announced the closing of its round B of financing, of $35 Million, led by aMoon, Israel's largest healthcare VC. All existing investors of the company – Lightspeed Venture Partners, LionBird, Corundum Open Innovation and Takoa – participated in the round.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
May 21,2019

Biofourmis Closes $35 Million Series B Financing Round to Advance Artificial Intelligence-Powered Digital Medicine Platform

Biofourmis, a fast-growing leader in digital medicine, today announced that it has successfully closed $35 million in Series B financing. The new injection of funding and move to the U.S. will enable Biofourmis to advance its proprietary artificial intelligence (AI)-powered digital medicine platform and pipeline that treats and manages a range of complex chronic conditions.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Sep 17,2019

One Drop Launches Global Commercial Partnership with Bayer and Announces $40M in Series B Financing

One Drop, a leader in the development of digital therapeutic solutions for diabetes and other chronic conditions, today announced $40 million in Series B financing, led by Bayer, one of the largest pharmaceutical companies in the world. Bayer has also entered a commercial licensing agreement to use One Drop’s platform in Bayer’s global bio-digital efforts in therapeutic areas such as oncology, cardiovascular disease, and women’s health. Stefan Oelrich, the President of Bayer Pharmaceuticals, will join One Drop’s Board of Directors.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Aug 02,2019

Hello Heart Secures $12M in Funding for Mobile Health Solution

Hello Heart recently completed a $12M Series B led by Khosla Ventures, a top-tier firm who’s active in AI and health investments. With this funding, Hello Heart is plans to take its operations to the next level and improve upon their mobile health solution.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Aug 28,2018

Renovia raises $32.3M for app-connected pelvic floor therapy system

Last week Renovia, maker of an FDA-cleared, app-based system for pelvic floor disorder management and therapy, announced the closure of a $32.3 million Series B equity round and an additional $10 million of debt financing. The round was led by Perceptive Advisors and Ascension Ventures, with additional participation from Longwood Fund, Inova Strategic Investments, Cormorant Asset Management, OSF Ventures, and Western Technology Investment. According to a statement, the new backing will be put toward clinical trials, corporate development, development of the company’s product pipeline, and supporting upcoming commercial launches.

FUNDING SERIES B

#connected device

#mobile app

View Analyst & Ambassador Comments
Go to original news
Subscribe to SERIES B